These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9848086)

  • 1. Possible causes of Alzheimer's disease: amyloid fragments, free radicals, and calcium homeostasis.
    Hölscher C
    Neurobiol Dis; 1998 Sep; 5(3):129-41. PubMed ID: 9848086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.
    Kawahara M; Negishi-Kato M; Sadakane Y
    Expert Rev Neurother; 2009 May; 9(5):681-93. PubMed ID: 19402778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.
    Hölscher C
    Rev Neurosci; 2005; 16(3):181-212. PubMed ID: 16323560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Change of fibroblast calcium levels caused by beta-amyloid peptide in Alzheimer disease].
    Palotás A; Kálmán J; Laskay G; Juhász A; Janka Z; Penke B
    Ideggyogy Sz; 2002 May; 55(5-6):164-7. PubMed ID: 12122875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurotoxicity of Alzheimer's beta-amyloid protein and membrane lipids].
    Kawahara M; Kuroda Y
    Tanpakushitsu Kakusan Koso; 1999 Oct; 44(13):1982-7. PubMed ID: 10517107
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium dysregulation in Alzheimer's disease.
    Bojarski L; Herms J; Kuznicki J
    Neurochem Int; 2008; 52(4-5):621-33. PubMed ID: 18035450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking calcium to Abeta and Alzheimer's disease.
    Green KN; LaFerla FM
    Neuron; 2008 Jul; 59(2):190-4. PubMed ID: 18667147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oxidative stress, beta-amyloide peptide and Alzheimer's disease].
    Manzano-León N; Mas-Oliva J
    Gac Med Mex; 2006; 142(3):229-38. PubMed ID: 16875352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
    Ferreiro E; Resende R; Costa R; Oliveira CR; Pereira CM
    Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper and Alzheimer's disease.
    Donnelly PS; Xiao Z; Wedd AG
    Curr Opin Chem Biol; 2007 Apr; 11(2):128-33. PubMed ID: 17300982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of intracellular A beta in Alzheimer's disease].
    Tabira T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):175-80. PubMed ID: 12451689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease.
    Drago D; Cavaliere A; Mascetra N; Ciavardelli D; di Ilio C; Zatta P; Sensi SL
    Rejuvenation Res; 2008 Oct; 11(5):861-71. PubMed ID: 18788899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol modulates amyloid beta-peptide's membrane interactions.
    Eckert GP; Kirsch C; Leutz S; Wood WG; Müller WE
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S136-43. PubMed ID: 14574628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42).
    Sultana R; Perluigi M; Butterfield DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals.
    Smith IF; Green KN; LaFerla FM
    Cell Calcium; 2005; 38(3-4):427-37. PubMed ID: 16125228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol trafficking and amyloid beta peptides.
    Wood WG; Igbavboa U
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S144-8. PubMed ID: 14574629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
    Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
    Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.